CNS Pharmaceuticals (CNSP)

• Market cap: $8.51M
• 1 day: 20%
• 5 days: 14.57%
• 1 month: 21.76%
• 3 months: 156.39%
• 6 months: 7.58%
• Year to date: 9.81%
• 1 year: -27.07%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Employees: 8